|
If you can't see the graphic version of this
message please change your profile to receive text messages at {{user("unsubaddr")}} To view this message on the web go to http://www.itcnewsletter.com/2004/2004-03.htm |
|
March 2004 |
Volume 5, Issue 3 |
|
In This Issue: |
Welcome |
|
Call for Papers |
Hello Again {{user("firstname")}}, We're glad to have you with us. Our bulletin boards have been active with many posts this last month. Check out a selection of the latest posts; you might find some information that will directly help you. Our main article this month, about breast cancer thermography, provides information that could directly affect many of us. Read about how infrared can provide an additional diagnostic modality to detect this disease. Can you find the unusual thermal pattern(s) in our latest Brainteaser? Check it out and let me know what you think at Brainteaser of the Month. If you want to save this newsletter for
viewing off line in your computer, just go to the web
page using your
browser and select File....Save As or
See you next month, Gary Orlove, |
| IR in the News [top] |
|
| ITC Message Board Posts [top] |
|
Our message boards have been busy. Here is a selection of recent new threads by IR Community members. Feel free to click the links, see how people have responded, and post your own response if you like.
And of course if YOU have a question or want to start a discussion on a topic, we would love to hear from you. Just post a new thread on a message board. |
| Medical Infrared Imaging [top] | ||
|
Medical infrared imaging (MII) is becoming a common screening modality in the areas of neuromusculoskeletal injury, cancer, and circulatory pathology. As a physiological imaging modality that assesses body function, it can indicate developing disease states – and breast cancer – earlier than anatomical examinations. It is highly accurate and 100% safe, involving no radiation or contact. MII is helpful for chronic pain, disease processes, and monitoring treatment effectiveness on physiology. MII can help to identify sources of pain, particularly those involving the neuromuscular and circulatory systems. Additionally, because every organ reflects itself on the skin surface, organ stress/compromise can be monitored. If disease processes are present, thermographic signs may present themselves before symptoms become apparent, enabling early intervention and treatment. The FDA approved the technology for adjunctive breast cancer screening in 1982, and it has been recognized as a viable diagnostic tool since 1987 by the AMA council on Scientific Affairs, the ACA Council on Diagnostic Imaging and the Congress of Neuro-Surgeons since 1988, and the American Academy of Physical Medicine and Rehabilitation since 1990. Research indicates that it is extremely effective in diagnosing most types of back, neck, and limb pain, especially latent or intractable types of pain syndromes. Four ways in which MII services help physicians and their breast patients:
The breast imaging procedure is based on the principle that chemical and blood vessel activity in both pre-cancerous tissue and the area surrounding a developing breast cancer is almost always higher than in the normal breast. Since pre-cancerous and cancerous masses are highly metabolic tissues, they need an abundant supply of nutrients to maintain their growth. In order to do this they increase circulation to their cells by secreting chemicals to keep existing blood vessels open, recruit dormant vessels, and create new ones (neoangiogenesis). This process results in an increase in regional surface temperatures of the breast. State-of-the-art applications use ultra-sensitive infrared cameras and sophisticated computers to detect, analyze, and produce high-resolution diagnostic images of these temperature and vascular changes.
This 35 year-old patient (above) had a normal mammogram the month prior to infrared imaging. Armed with a diagnostic report including severely abnormal findings in the right breast, the patient requested a biopsy and discovered Stage I cancer with a 1cm lump, a second smaller lump, and lymph node involvement. Chemotherapy was initiated. (Note two abnormal thermal findings consistent with cancer: vascular signs of neoangiogenesis, shown in grayscale, and abnormally-high temperatures, shown in color.)
By carefully examining aspects of temperature and blood vessels of the breasts, signs of possible cancer or pre-cancerous cell growth may be detected up to 10 years prior to being discovered using any other procedure. This provides the earliest detection of cancer possible. Because of infrared imaging’s extreme sensitivity, these temperature variations and vascular changes may be among the earliest signs of breast cancer and/or a pre-cancerous state of the breast. (3,6,7,8,9) Thermal studies of the breast have been researched for over 30 years, and over 800 peer-reviewed studies exist in the index-medicus. Over 3,000 articles are accessible through MedLine. Over 300,000 women have been included as study participants, with many studies including 37,000 to 118,000 women. Some of these studies have followed patients up to 12 years. Studies show that:
In the absence of other positive tests, an abnormal infrared image gives a woman early warning and the need for intervention, or change in lifestyle, diet, or other breast health factors. By maintaining close monitoring of her breast health with serial infrared imaging, a woman can monitor breast health and has a much better chance of detecting cancer at its earliest stage and preventing invasive tumor growth.
The addition of infrared imaging to the frontline of early breast cancer detection brings a great deal of good news for women. For more
information, visit www.thermogramcenter.com or
www.iact-org.org. Tirza and Dr. Kane can be reached at 303-664-1139 and 650-568-9292 respectively. References 1. American Cancer Society – Breast Cancer Guidelines and Statistics, 1999 2. I. Nyirjesy, M.D. et al; Clinical Evaluation, Mammography and Thermography in the Diagnosis of Breast Carcinoma. Thermology, 1986; 1: 170-173. 3. M. Gautherie, Ph.D.; Thermobiological Assessment of Benign and Malignant Breast Diseases. Am. J. Obstet. Gynecol., 1983; V 147, No. 8: 861-869. 4. C. Gros, M.D., M. Gautherie, Ph.D.; Breast Thermography and Cancer Risk Prediction. Cancer, 1980; V 45, No. 1: 51-56. 5. P. Haehnel, M.D., M. Gautherie, Ph.D. et al; Long-Term Assessment of Breast Cancer Risk by Thermal Imaging. In: Biomedical Thermology, 1980; 279-301. 6. P. Gamigami, M.D.; Atlas of Mammography: New Early Signs in Breast Cancer. Blackwell Science, 1996. 7. J. Keyserlingk, M.D.; Time to Reassess the Value of Infrared Breast Imaging? Oncology News Int., 1997; V 6, No. 9. 8. P.Ahlgren, M.D., E. Yu, M.D., J. Keyserlingk, M.D.; Is it Time to Reassess the Value of Infrared Breast Imaging? Primary Care & Cancer (NCI), 1998; V 18, No. 2. 9. N. Belliveau, M.D., J. Keyserlingk, M.D. et al ; Infrared Imaging of the Breast: Initial Reappraisal Using High-Resolution Digital Technology in 100 Successive Cases of Stage I and II Breast Cancer. Breast Journal, 1998; V 4, No. 4 Editor's note: Tirza and Dr. Kane each receive an InfraMation Executive Attaché in appreciation for their article contribution. |
|
Click here to email your guess Do you have an interesting image that you think would stump other thermographers? If so please email me your image (preferably in native .img, .jpg, .tif, .tgw, or .tmw format) with an accompanying visible photo and explanation. If your image is used, you receive a gift as well. |
| Last Month's Brainteaser [top] |
|
Thanks to Dan Sinclair for the thermogram and congratulations to last month's winner, Clay Boyd of Duke Energy. Dan and Clay each receive a special low emissivity traveling coffee mug. |
|
Click the links below to view past issues of this newsletter: |
||
|
Click the links below to see our latest course calendars (in local language). |
||
|
The Infrared Training Center offers training and certification in all aspects of infrared thermography use. Our world-class training facilities are located near Boston, Massachusetts, USA and Stockholm, Sweden and have the world's most extensive hands on laboratories for infrared applications. Please join us in exploring the fascinating world of the infrared! Your comments and suggestions about this newsletter are welcomed and encouraged. If you have an interesting application or case study to share, we encourage you to submit it for publication. Published articles earn credit towards recertification. Please e-mail Gary Orlove or send regular mail to the Americas office. Visit our website: |
ITC Americas, BOSTON 16 Esquire Road Tel: +1-978-901-8405
|
ITC Eurasia, SWEDEN Rinkebyvägen 19 Tel: +46 (0) 8 753 25 00
|
|
THIS DOCUMENT
IS FOR INFORMATIONAL PURPOSES ONLY. INFORMATION PROVIDED IN THIS DOCUMENT IS
PROVIDED 'AS IS' WITHOUT WARRANTY OF ANY KIND. The user assumes the entire
risk as to the accuracy and the use of this document. The Infrared Training
Center newsletter may be copied and distributed subject to the following
conditions: 1. All text and images must be copied without modification and
all pages must be included; 2. All copies must contain the Infrared Training
Center copyright notice and any other notices provided therein; ©2004 Infrared Training Center - All rights reserved |
||
|
Privacy Statement: We're happy to have you on our list, and since we want to keep you all to ourselves, we never share your e-mail address with anyone. Period. Is this still your favorite email account? Click to change it here. To unsubscribe or update your user profile, click here. New subscriber signup, click here. |